Financial News
Cyren Announces Second Quarter 2021 Financial Results
Cyren Inbox Security, Anti-Phishing for the Enterprise, Achieves Record ARR Growth
MCLEAN, VA / ACCESSWIRE / August 16, 2021 / Cyren (NASDAQ:CYRN) today announced its second quarter 2021 financial results for the period ending June 30, 2021.
During the second quarter, Cyren reported quarterly revenues of $7.6 million, compared to $9.2 million during the second quarter of 2020. GAAP net loss for the quarter was $5.6 million, compared to the $4.6 million net loss reported during the second quarter of 2020, due to lower revenues, partially offset by lower operating expenses compared to the prior year.
"While overall revenues declined year-over-year, this decline was predominantly within our legacy threat intelligence services OEM business. Churn in the quarter was very low and customer satisfaction has never been higher. However, we had some anticipated customer contract reductions, with some occurring in 2020, that impacted the year-over-year comparison", said Brett Jackson, CEO of Cyren.
"In our opinion, the key Q2 highlight for shareholders, however, is the significant acceleration of our new enterprise anti-phishing business, led by our Cyren Inbox Security offering. This acceleration was driven by an increase in customer order volume which resulted in new and expansion ARR growth of approximately 240% from Q1 2021. We believe this acceleration is likely to continue in Q3 based on the strength of our pipeline and the number of customer orders closed quarter-to-date."
"As we have mentioned in prior calls, Cyren's biggest growth opportunity is helping enterprise customers effectively deal with the constant stream of phishing attacks and business email compromise attempts. We believe our Q2 results and exceptional win rate validate the effectiveness and competitive differentiation of Cyren Inbox Security and its ability to quickly solve enterprise customers' phishing problems. Management will continue to focus on investing in and developing this new, high-growth revenue stream and its potential to drive shareholder value."
Second Quarter 2021 Financial Highlights:
- Revenues for the second quarter of 2021 were $7.6 million, compared to $9.2 million during the second quarter of 2020.
- GAAP net loss for the second quarter of 2020 was $5.6 million, compared to a net loss of $4.6 million in the second quarter of 2020.
- GAAP loss per basic and diluted share for the second quarter of 2021 was $0.07, compared to a loss of $0.08 per basic and diluted share for the second quarter of 2020.
- Non-GAAP net loss for the second quarter of 2021 was $4.5 million, compared to a Non-GAAP net loss of $3.8 million for the second quarter of 2020.
- Non-GAAP loss per basic and diluted share was $0.06 for the Q2 2021, compared to a Non-GAAP loss of $0.06 per share in Q2 2020.
- Cash used in operating activities during the second quarter of 2021 was $2.3 million, compared to cash provided by operating activities of $2.5 million during the second quarter of 2020, largely driven by an increase in net loss, a decline in deferred revenue driven by the receipt of a multi-year, multi-million dollar prepayment from one of our largest customers in the first quarter of 2019 and a decline in deferred revenue due to downsells on various customer renewals.
- Net cash flow for the second quarter of 2021 was negative $2.5 million, compared to positive $1.1 million during the second quarter of 2020.
- Cash and cash equivalents balance as of June 30, 2021, was $13.9 million, compared to $9.3 million as of December 31, 2020.
For information regarding the non-GAAP financial measures discussed in this release, please see "Use of Non-GAAP Financial Measures" and "Reconciliation of Selected GAAP Measures to Non-GAAP Measures."
Financial Results Conference Call:
The company will host a conference call at 4:30 p.m. a.m. Eastern Time (11:30 p.m. Israel Time) on Monday, August 16, 2021 to discuss second quarter results.
U.S. Dial-in Number: 1-877-407-0312
Israel Dial-in Number: 1-80-940-6247
International Dial-in Number: 1-201-389-0899
The call will be simultaneously webcast live on the investor relations section of Cyren's website at https://ir.cyren.com, or by using the following link: https://www.webcast-eqs.com/cyren_08162021/en.
For those unable to participate in the live conference call, a replay will be available until August 30, 2021. To access the replay, the U.S. dial in number is 1-877-660-6853 and the non-U.S. dial in number is 1-201-612-7415. Callers will be prompted for replay conference ID number 13722129. An archived version of the webcast will also be available on the investor relations section of the company's website at https://ir.cyren.com/events.
About Cyren:
More than 1.3 billion users around the world rely on Cyren's cloud security solutions to protect them against cyber attacks and data loss every day. Powered by GlobalView, Cyren's global security cloud that identifies emerging threats on a global basis in real-time, Cyren (NASDAQ:CYRN) delivers fast time-to-protection with threat detection services, threat intelligence and enterprise email security products for leading email providers, cybersecurity vendors, service providers and enterprises. Learn more at www.cyren.com.
Blog: http://blog.cyren.com
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc
Use of Non-GAAP Financial Measures:
Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, and deferred taxes related to acquisitions, adjustments to earn-out obligations, and capitalization of technology. The purpose of such adjustments is to give an indication of the company's performance exclusive of non-cash charges and other items that are considered by management to be outside of the company's core operating results. The company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.
Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.
These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company's current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company's publicly filed reports, which are available through www.sec.gov.
Company Contact
Kenneth Tarpey, CFO
Cyren
+1 (703) 760-3435
kenneth.tarpey@cyren.com
CYREN LTD. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands of U.S. dollars, except per share amounts) | ||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
June 30 | June 30 | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Unaudited | Unaudited | Unaudited | Unaudited | |||||||||||||
Revenues | $ | 7,609 | $ | 9,181 | $ | 16,366 | $ | 18,830 | ||||||||
Cost of revenues | 3,805 | 3,778 | 7,600 | 7,376 | ||||||||||||
Gross profit | 3,804 | 5,403 | 8,766 | 11,454 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development, net | 4,110 | 4,151 | 8,360 | 7,495 | ||||||||||||
Sales and marketing | 2,731 | 3,146 | 5,369 | 6,182 | ||||||||||||
General and administrative | 2,305 | 2,476 | 4,465 | 4,690 | ||||||||||||
Total operating expenses | 9,146 | 9,773 | 18,194 | 18,367 | ||||||||||||
Operating loss | (5,342 | ) | (4,370 | ) | (9,428 | ) | (6,913 | ) | ||||||||
Other income, net | 1 | 2 | (17 | ) | 8 | |||||||||||
Financial expenses, net | (287 | ) | (290 | ) | (501 | ) | (521 | ) | ||||||||
Loss before taxes | (5,628 | ) | (4,658 | ) | (9,946 | ) | (7,426 | ) | ||||||||
Tax benefit | 40 | 44 | 161 | 61 | ||||||||||||
Net loss | $ | (5,588 | ) | $ | (4,614 | ) | $ | (9,785 | ) | $ | (7,365 | ) | ||||
Loss per share - basic and diluted | $ | (0.07 | ) | $ | (0.08 | ) | $ | (0.14 | ) | $ | (0.12 | ) | ||||
Weighted average number of shares outstanding: | ||||||||||||||||
Basic and Diluted | 75,484 | 60,041 | 71,996 | 59,862 | ||||||||||||
CYREN LTD. RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES (in thousands of U.S. dollars, except per share amounts) | ||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
June 30 | June 30 | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Unaudited | Unaudited | Unaudited | Unaudited | |||||||||||||
GAAP gross profit | $ | 3,804 | $ | 5,403 | $ | 8,766 | $ | 11,454 | ||||||||
GAAP gross margin | 50% | 59% | 54% | 61% | ||||||||||||
Plus: | ||||||||||||||||
Stock-based compensation expense | 83 | 20 | 104 | 64 | ||||||||||||
Amortization of intangible assets | 658 | 593 | 1,325 | 1,024 | ||||||||||||
Non-GAAP gross profit | 4,545 | 6,016 | 10,195 | 12,542 | ||||||||||||
Non-GAAP gross margin | 60% | 66% | 62% | 67% | ||||||||||||
GAAP operating loss | (5,342 | ) | (4,370 | ) | (9,428 | ) | (6,913 | ) | ||||||||
Plus: | ||||||||||||||||
Stock-based compensation expense | 548 | 507 | 1,005 | 1,152 | ||||||||||||
Amortization of intangible assets | 734 | 723 | 1,476 | 1,283 | ||||||||||||
Capitalization of technology | (88 | ) | (389 | ) | (239 | ) | (1,602 | ) | ||||||||
Non-GAAP operating loss | (4,148 | ) | (3,529 | ) | (7,186 | ) | (6,080 | ) | ||||||||
GAAP net loss | (5,588 | ) | (4,614 | ) | (9,785 | ) | (7,365 | ) | ||||||||
Plus: | ||||||||||||||||
Stock-based compensation expense | 548 | 507 | 1,005 | 1,152 | ||||||||||||
Amortization of intangible assets | 734 | 723 | 1,476 | 1,283 | ||||||||||||
Amortization of deferred tax assets | (55 | ) | (48 | ) | (109 | ) | (96 | ) | ||||||||
Capitalization of technology | (99 | ) | (414 | ) | (262 | ) | (1,657 | ) | ||||||||
Non-GAAP net loss | $ | (4,460 | ) | $ | (3,846 | ) | $ | (7,675 | ) | $ | (6,683 | ) | ||||
Numerator for non-GAAP EPS calculation | $ | (4,460 | ) | $ | (3,846 | ) | $ | (7,675 | ) | $ | (6,683 | ) | ||||
Non-GAAP net loss per share | $ | (0.06 | ) | $ | (0.06 | ) | $ | (0.11 | ) | $ | (0.11 | ) | ||||
GAAP weighted-average shares used to | ||||||||||||||||
compute net loss per share | 75,484 | 60,041 | 71,996 | 59,862 | ||||||||||||
CYREN LTD. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands of U.S. dollars) | ||||||||
June 30 | December 31 | |||||||
2021 | 2020 | |||||||
Unaudited | ||||||||
Assets | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 13,885 | $ | 9,296 | ||||
Trade receivables, net | 1,410 | 960 | ||||||
Deferred commissions | 989 | 980 | ||||||
Prepaid expenses and other receivables | 1,615 | 779 | ||||||
Total current assets | 17,899 | 12,015 | ||||||
Long-term deferred commissions | 938 | 1,125 | ||||||
Long-term lease deposits and prepaids | 870 | 937 | ||||||
Operating lease right-of-use assets | 9,852 | 10,900 | ||||||
Severance pay fund | 808 | 745 | ||||||
Property and equipment, net | 3,248 | 3,948 | ||||||
Intangible assets, net | 6,536 | 7,797 | ||||||
Goodwill | 21,022 | 21,476 | ||||||
Total long-term assets | 43,274 | 46,928 | ||||||
Total assets | $ | 61,173 | $ | 58,943 | ||||
Liabilities and Shareholders' Equity | ||||||||
Current Liabilities: | ||||||||
Trade payables | $ | 1,361 | $ | 799 | ||||
Convertible notes | 10,000 | 10,000 | ||||||
Employees and payroll accruals | 3,898 | 3,813 | ||||||
Accrued expenses and other liabilities | 907 | 1,420 | ||||||
Operating lease liabilities | 1,782 | 1,983 | ||||||
Deferred revenues | 6,791 | 6,934 | ||||||
Total current liabilities | 24,739 | 24,949 | ||||||
Deferred revenues | 524 | 644 | ||||||
Convertible debentures | 8,497 | 9,248 | ||||||
Long-term operating lease liabilities | 8,894 | 9,866 | ||||||
Deferred tax liability | 472 | 655 | ||||||
Accrued severance pay | 902 | 838 | ||||||
Other liabilities | 527 | 706 | ||||||
Total long-term liabilities | 19,816 | 21,957 | ||||||
Shareholders' equity | 16,618 | 12,037 | ||||||
Total liabilities and shareholders' equity | $ | 61,173 | $ | 58,943 | ||||
CYREN LTD. CONDENSED CONSOLIDATED CASH FLOW DATA (in thousands of U.S. dollars) | ||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
June 30 | June 30 | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Cash flows from operating activities: | Unaudited | Unaudited | Unaudited | Unaudited | ||||||||||||
Net loss | $ | (5,588 | ) | $ | (4,614 | ) | (9,785 | ) | $ | (7,365 | ) | |||||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||||||||||||
(Gain) / loss on disposal of property and equipment | (1 | ) | 26 | 17 | 13 | |||||||||||
Depreciation | 528 | 597 | 1,091 | 1,215 | ||||||||||||
Stock-based compensation | 548 | 507 | 1,005 | 1,152 | ||||||||||||
Amortization of intangible assets | 733 | 723 | 1,475 | 1,283 | ||||||||||||
Amortization of deferred commissions | 328 | 452 | 653 | 803 | ||||||||||||
Non-cash operating lease expense | 464 | 534 | 930 | 922 | ||||||||||||
Interest on convertible notes | 143 | 142 | 285 | 283 | ||||||||||||
Interest and amortization of debt issuance costs on Convertible Debentures | 167 | 187 | 343 | 211 | ||||||||||||
Deferred taxes, net | (44 | ) | (54 | ) | (168 | ) | (118 | ) | ||||||||
Changes in assets and liabilities: | ||||||||||||||||
Trade receivables | (682 | ) | 490 | (471 | ) | (162 | ) | |||||||||
Prepaid expenses and other receivables | (794 | ) | (57 | ) | (792 | ) | (383 | ) | ||||||||
Deferred commissions | (266 | ) | (276 | ) | (474 | ) | (664 | ) | ||||||||
Change in long-term lease deposits and prepaids | 18 | 28 | 20 | (86 | ) | |||||||||||
Trade payables | 185 | (159 | ) | 247 | (114 | ) | ||||||||||
Employees and payroll accruals, accrued expenses and other liabilities | (372 | ) | 444 | (548 | ) | (47 | ) | |||||||||
Deferred revenues | 2,592 | 4,062 | (182 | ) | 1,989 | |||||||||||
Accrued severance pay, net | 23 | 24 | 2 | 1 | ||||||||||||
Operating lease liabilities | (333 | ) | (534 | ) | (1,064 | ) | (954 | ) | ||||||||
Other long-term liabilities | 6 | 10 | (180 | ) | 163 | |||||||||||
Net cash provided by (used in) operating activities | (2,345 | ) | 2,532 | (7,596 | ) | (1,858 | ) | |||||||||
Cash flows from investing activities: | ||||||||||||||||
Proceeds from sale of property and equipment | 3 | 2 | 5 | 4 | ||||||||||||
Capitalization of technology | (100 | ) | (588 | ) | (252 | ) | (1,589 | ) | ||||||||
Purchase of property and equipment | (115 | ) | (880 | ) | (133 | ) | (1,438 | ) | ||||||||
Net cash used in investing activities | (212 | ) | (1,466 | ) | (380 | ) | (3,023 | ) | ||||||||
Cash flows from financing activities: | ||||||||||||||||
Proceeds from Convertible Debenture, net of debt issuance costs | - | - | - | 9,442 | ||||||||||||
Proceeds from stock issuance, net of costs | - | - | 12,588 | - | ||||||||||||
Net cash provided by financing activities | - | - | 12,588 | 9,442 | ||||||||||||
Effect of exchange rate changes on cash | 8 | (7 | ) | (22 | ) | (13 | ) | |||||||||
Increase (decrease) in cash, cash equivalents and restricted cash | (2,549 | ) | 1,059 | 4,590 | 4,548 | |||||||||||
Cash, cash equivalents and restricted cash at the beginning of the period | 17,053 | 15,616 | 9,914 | 12,127 | ||||||||||||
Cash, cash equivalents and restricted cash at the end of the period | $ | 14,504 | $ | 16,675 | $ | 14,504 | $ | 16,675 | ||||||||
Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flow: | ||||||||||||||||
Cash and cash equivalents | $ | 13,885 | $ | 16,103 | $ | 13,885 | $ | 16,103 | ||||||||
Restricted cash included in long-term restricted lease deposits | 619 | 572 | 619 | 572 | ||||||||||||
Total cash, cash equivalents and restricted cash | $ | 14,504 | $ | 16,675 | $ | 14,504 | $ | 16,675 | ||||||||
SOURCE: Cyren Ltd
View source version on accesswire.com:
https://www.accesswire.com/659995/Cyren-Announces-Second-Quarter-2021-Financial-Results
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.